Alzchem Group delivered record sales and EBITDA in 2024, driven by Specialty Chemicals, with strong cash flow, a higher dividend, and a positive outlook for 2025. Investments in capacity and sustainability support future growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.